[Clinical Features and Prognosis of Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma].
Primary EN-DLBCL can involve multiple organs or tissue sites. <i>TP53</i> , <i>MYD88</i> , and <i>CD79B</i> are the most common gene mutations. The efficacy of BTKi in patients with positive MCD subtypes at intermediate and high risk is not inferior to that in MCD-negative control patients.
Authors
- Ting Niu
- Huan Tao
- Yu Wu (ORCID: https://orcid.org/0000-0001-8708-9711)
- Hongbing Ma (ORCID: https://orcid.org/0000-0002-1174-4078)
- Xia Li (ORCID: https://orcid.org/0000-0003-3050-8529)
- Yongqian Jia
- Jie Ji (ORCID: https://orcid.org/0000-0003-4038-9180)
- Yi Si
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Jiujiang First People's Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.06.012
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article